EGM
TBPH icon

Engineers Gate Manager’s Theravance Biopharma TBPH Stock Holding History

Engineers Gate Manager’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Sell
100,136
-13,085
-12% -$217K 0.02% 773
2026
Q1 		$1.84M Buy
113,221
+72,213
+176% +$1.28M 0.02% 751
2025
Q4 		$767K Buy
41,008
+18,723
+84% +$311K 0.01% 1167
2025
Q3 		$325K Buy
22,285
+8,628
+63% +$109K ﹤0.01% 1707
2025
Q2 		$151K Buy
+13,657
New +$133K ﹤0.01% 1937
2025
Q1 		– Sell
-19,832
Closed -$187K – 2573
2024
Q4 		$187K Sell
19,832
-7,193
-27% -$65.5K ﹤0.01% 1897
2024
Q3 		$218K Buy
27,025
+7,548
+39% +$65.4K ﹤0.01% 1772
2024
Q2 		$165K Buy
19,477
+7,556
+63% +$68.2K ﹤0.01% 1676
2024
Q1 		$107K Sell
11,921
-13,058
-52% -$121K ﹤0.01% 1736
2023
Q4 		$281K Buy
+24,979
New +$251K 0.01% 1491
2021
Q4 		– Sell
-18,482
Closed -$137K – 2287
2021
Q3 		$137K Buy
+18,482
New +$207K 0.01% 1495
2021
Q1 		– Sell
-18,051
Closed -$321K – 2116
2020
Q4 		$321K Buy
+18,051
New +$324K 0.01% 1257
2020
Q3 		– Sell
-73,667
Closed -$1.55M – 1977
2020
Q2 		$1.55M Buy
73,667
+33,046
+81% +$849K 0.08% 383
2020
Q1 		$939K Buy
40,621
+4,886
+14% +$122K 0.07% 462
2019
Q4 		$925K Buy
35,735
+7,891
+28% +$153K 0.04% 685
2019
Q3 		$542K Sell
27,844
-14,627
-34% -$296K 0.03% 747
2019
Q2 		$694K Buy
+42,471
New +$860K 0.04% 612
2018
Q4 		– Sell
-20,262
Closed -$662K – 1125
2018
Q3 		$662K Buy
+20,262
New +$552K 0.05% 442

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Engineers Gate Manager's TBPH Position: Q2 2026 in Review

Engineers Gate Manager reduced its Theravance Biopharma (TBPH) stake by 12% in Q2 2026, selling an estimated $217K and leaving 100,136 shares worth $1.7M. The position accounts for 0.02% of the portfolio, ranked #773.

Engineers Gate Manager first reported a position in TBPH in Q3 2018 and has held it in 18 quarters since. The position peaked at $1.84M in Q1 2026. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Engineers Gate Manager held 100,136 shares of Theravance Biopharma worth $1.7M as of Q2 2026.
  • Engineers Gate Manager sold 13,085 Theravance Biopharma shares in Q2 2026, an estimated $217K.
  • Theravance Biopharma made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #773 holding.
  • Engineers Gate Manager first reported a position in Theravance Biopharma in Q3 2018 and has held it in 18 quarters since.
  • Engineers Gate Manager's Theravance Biopharma position peaked at $1.84M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.